The phytochemical honokiol, an HDAC inhibitor, reduced the viability of several NSCLC cell lines, inducing a predictable G1 phase arrest, and inhibited the growth of lung tumor xenografts (Singh et al., 2013). Here, HDAC9 is linked to non-small cell lung carcinoma.